Adverse Immune Effects of Nanomedicines and Biologicals– Under the Microscope

Hosted By: Helen Winsor
Rate this Podcast: 
Be the first!
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

About this Podcast...

Janos Szebeni, Director of the Nanomedicine Research and Education Center, Bay Zoltan Foundation for Applied Research at Semmelweis University, Budapest, joins Helen Winsor Pharma IQ, to discuss developments in immunogenicity. In this exclusive interview, Szebeni talks about the aims of his current research and how this will affect our current understanding of immunogenicity. He outlines the main challenges faced and the best practice methods that have been put in place to overcome these setbacks. 


Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018